Stephen R. Brady, CEO of Tempest Therapeutics TPST, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/01/02.

SB

SB

Stephen R. Brady

President and CEO

Company

Tempest Therapeutics TPST

First filing

23/01/05

Trades

6 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/01/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Tempest TherapeuticsTPST	Open-market buy	24/07/03	24/07/08	35,000 sh	$2.11	$73,850	+307.7%